<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="any beneficial effect of Ocimum sanctum (Linn) (OS) in experimental" exact="pulmonary hypertension" post="(PH) in rats. OS is commonly known as &quot;holy"/>
 <result pre="The effect of OS was comparable with sildenafil. Ocimum sanctum" exact="pulmonary hypertension" post="echocardiography percentage medial wall thickness Nox 1. Introduction Ocimum"/>
 <result pre="our hypothesis that it might have a salutary effect in" exact="pulmonary hypertension." post="Pulmonary hypertension (PH) is defined and diagnosed hemodynamically as"/>
 <result pre="Ifedigbo E. Kanno S. Otterbein L.E. Carbon monoxide reverses established" exact="pulmonary hypertension" post="J. Exp. Med. 2006 203 2109 2119 10.1084/jem.20052267 16908624"/>
 <result pre="murine pulmonary arterial pressure: Validation and application to models of" exact="pulmonary hypertension" post="Circ. Cardiovasc. Imaging 2010 3 157 163 10.1161/CIRCIMAGING.109.887109 20044514"/>
 <result pre="Ghofrani H.A. et al. Therapeutic efficacy of TBC3711 in monocrotaline-induced" exact="pulmonary hypertension" post="Respir. Res. 2011 12 87 10.1186/1465-9921-12-87 21699729 28. Jones"/>
 <result pre="G. Loscalzo J. Zhang Y.-Y. Serial noninvasive assessment of progressive" exact="pulmonary hypertension" post="in a rat model Am. J. Physiol. Heart Circ."/>
 <result pre="W.R. Gerdes A.M. McDonough K.H. Right ventricular performance after monocrotaline-induced" exact="pulmonary hypertension" post="Am. J. Physiol. 1989 256 H1328 H1336 10.1152/ajpheart.1989.256.5.H1328 2524170"/>
 <result pre="Tuder R.M. Hassoun P.M. Johns R.A. Attenuation of chronic hypoxic" exact="pulmonary hypertension" post="by simvastatin Am. J. Physiol. Heart Circ. Physiol. 2003"/>
 <result pre="decreases myocardial injury and improves right ventricular function in monocrotaline-induced" exact="pulmonary hypertension" post="Am. J. Physiol. Heart Circ. Physiol. 2009 296 H2007"/>
 <result pre="antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of" exact="pulmonary hypertension" post="and endothelial metabolic dysfunction in monocrotaline-treated rats J. Pharmacol."/>
 <result pre="and evolution of pulmonary vascular disease in rats with monocrotaline" exact="pulmonary hypertension" post="Thorax 1982 37 88 96 10.1136/thx.37.2.88 6281933 39. Ohkawa"/>
 <result pre="novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2" exact="cardiomyopathy" post="J. Mol. Cell. Cardiol. 2010 49 683 692 10.1016/j.yjmcc.2010.06.003"/>
 <result pre="bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental" exact="pulmonary hypertension" post="J. Ethnopharmacol. 2017 197 184 194 10.1016/j.jep.2016.07.029 27401289 45."/>
 <result pre="B. Sirmagul B. The effects of gender difference on monocrotaline-induced" exact="pulmonary hypertension" post="in rats Hum. Exp. Toxicol. 2013 32 766 774"/>
 <result pre="Evaluation of olmesartan medoxomil in the rat monocrotaline model of" exact="pulmonary hypertension" post="J. Cardiovasc. Pharmacol. 2008 51 18 23 10.1097/FJC.0b013e318159b01c 18209564"/>
 <result pre="J.C. Pulmonary vascular remodeling: A target for therapeutic intervention in" exact="pulmonary hypertension" post="Pharmacol. Ther. 2001 92 1 20 10.1016/S0163-7258(01)00157-7 11750034 50."/>
 <result pre="R.E. Growth factor expression and effects of amrinone in monocrotaline-induced" exact="pulmonary hypertension" post="in rats Biochem. Mol. Med. 1996 58 204 210"/>
 <result pre="P. Podlutsky A. Losonczy G. et al. Resveratrol prevents monocrotaline-induced" exact="pulmonary hypertension" post="in rats Hypertension 2009 54 668 675 10.1161/HYPERTENSIONAHA.109.133397 19597040"/>
 <result pre="K. A comprehensive review: The evolution of animal models in" exact="pulmonary hypertension" post="research; are we there yet? Pulm. Circ. 2013 3"/>
</results>
